Epidemiological burden of HPV and cervical cancer in Africa highlights improved screening and vaccination strategies, suggesting better outcomes with targeted interventions.
Though cervical cancer is largely preventable, Africa faces a high burden with thousands of deaths. Highlighting the urgent need for action toward the WHO’s 90-70-90 elimination strategy, this study presents the epidemiological burden of HPV and cervical cancer in Africa and advocates for decisive measures to improve screening and implement effective prevention through vaccination. Here, we discuss which is the better option for Africa: a single-dose or a two-dose vaccine regimen. Furthermore, we explore screening methods, such as methylation markers and AI-based screening, as well as treatment-related side effects and the prognosis of cervical cancer in Africa. Cervical cancer is a largely preventable disease that yet has a high burden and mortality rate in Africa. In here the authors review, the advancement in cervical cancer screening, treatment, and prognosis and advocate for decisive measures to enhance screening methods
No takes yet. Share an insight, caveat, or question.
Osafo et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: